secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch Health Companies Inc. (BHC)
CIK:        0000885590
Form:       8-K
Filed at:   2024-07-19T23:59:59+00:00
Accession:  0000950103-24-010257
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch Health appoints Jean-Jacques Charhon as CFO, Aimee Lenar as EVP US Pharma
--------------------------------------------------------------------------------

- Jean-Jacques Charhon named CFO effective Aug 19, 2024; base salary $700K, target bonus 60%, equity grants ~$3M.
- Charhon receives one-time sign-on cash bonus of $300K and sign-on equity grant of $3.5M (50% RSUs, 50% PSUs).
- Interim CFO John Barresi returns to SVP, Controller role; granted $350K retention RSU award vesting over 3 years.
- Barresi's enhanced severance extended to Dec 31, 2025; bi-weekly $5K stipend extended to Sep 30, 2024.
- Aimee Lenar joined Jul 15, 2024 as EVP US Pharma, leading Salix, Neurology, Generics, Market Access.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885590/000095010324010257/0000950103-24-010257-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885590/000095010324010257/dp214678_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-24-010257

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer